|
MyBiosource Biotechnology
ckd – progression ![]() Ckd – Progression, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ckd+progression/ckd+++progression/pmc11103316-75-7-5 Average 90 stars, based on 1 article reviews
ckd – progression - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Feline Medicine and Surgery
Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review
doi: 10.1177/1098612X241234984
Figure Lengend Snippet: Sample type, FGF-23 assay kit and study objectives for the 17 articles included in the scoping review
Article Snippet: Liao et al, 2019 ,
Techniques: Clinical Proteomics, Biomarker Discovery, Concentration Assay
Journal: Journal of Feline Medicine and Surgery
Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review
doi: 10.1177/1098612X241234984
Figure Lengend Snippet: Study type, country and time frame for sample collection, definition of CKD and inclusion/exclusion criteria for the studies of fibroblast growth factor 23 in cats
Article Snippet: Liao et al, 2019 ,
Techniques: Clinical Proteomics, Medications, Concentration Assay, Biomarker Discovery, Imaging
Journal: Journal of Feline Medicine and Surgery
Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review
doi: 10.1177/1098612X241234984
Figure Lengend Snippet: Article characteristics and population information for studies evaluating serum or plasma concentrations of fibroblast growth factor-23 (pg/mL) in healthy cats and in cats with CKD stages 1–4
Article Snippet: Liao et al, 2019 ,
Techniques: Clinical Proteomics
Journal: Journal of Feline Medicine and Surgery
Article Title: Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review
doi: 10.1177/1098612X241234984
Figure Lengend Snippet: Article characteristics and population information for studies evaluating serum or plasma concentrations of FGF-23 (pg/ml) in cats with progressive or non-progressive CKD
Article Snippet: Liao et al, 2019 ,
Techniques: Clinical Proteomics